Showing results (91-100 of 251) with videos related to
Sort By:
Pageof 26
Cancer Science|May 20, 2014
Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology GroupHaruyasu Murakami, Takeharu Yamanaka, Takashi Seto, et al.Oncology Reports|July 14, 2011
Expression of 4F2hc (CD98) in pulmonary neuroendocrine tumorsKyoichi Kaira, Yasuhisa Ohde, Masahiro Endo, et al.Investigational New Drugs|May 20, 2020
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trialKazuhisa Nakashima, Yuichi Ozawa, Haruko Daga, et al.Thoracic Cancer|January 26, 2023
Efficacy and safety of carboplatin and etoposide in older extensive-stage small-cell lung cancer patients with a poor performance statusNobuaki Mamesaya, Hiroaki Kodama, Yuko Iida, et al.BMC Cancer|January 16, 2014
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapyHiroaki Akamatsu, Keita Mori, Tateaki Naito, et al.Journal of Neuro-Oncology|March 28, 2023
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer centerKeisuke Kimura, Shoichi Deguchi, Koichi Mitsuya, et al.Cancer Chemotherapy and Pharmacology|August 2, 2017
Survival data for postoperative adjuvant chemotherapy comprising cisplatin plus vinorelbine after complete resection of non-small cell lung cancerHirotsugu Kenmotsu, Yasuhisa Ohde, Kazushige Wakuda, et al.Cancer Research|October 19, 2005
Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancersNobuhisa Ishikawa, Yataro Daigo, Atsushi Takano, et al.Internal Medicine (Tokyo, Japan)|December 17, 2013
Papillary squamous cell carcinoma of the trachea associated with human papillomavirus-18 infectionHisao Imai, Toshiaki Takahashi, Tetsuhiko Taira, et al.European Journal of Cancer (Oxford, England : 1990)|December 27, 2021
Trastuzumab emtansine for patients with non-small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutationsEiji Iwama, Yoshitaka Zenke, Shunichi Sugawara, et al.Pageof 26